Topics:

Cellectar opens manufacturing facility for radiolabeled CLR1404

Cellectar opens manufacturing facility for radiolabeled CLR1404

MADISON, Wisconsin—Cellectar has opened its new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison. The facility allows Cellectar to manufacture and radiolabel its lead compound CLR1404, a phospholipid ether combined with 131Iodine, in compliance with Good Manufacturing Practices.

 
Loading comments...
Please Wait 20 seconds or click here to close